Teda Biological (08189) announced its interim results, with a profit attributable to shareholders of 10.2083 million yuan, marking a year-on-year turnaround to profitability.
Teda Biotechnology (08189) announced its interim results for the six months ending June 30, 2026, with a revenue of 296 million yuan, an increase of 30.75% year-on-year; profit attributable to owners of the company was 10.2083 million yuan, compared to a loss of 6.4264 million yuan in the same period last year; earnings per share were 0.048 yuan.
Teda Biomedical (08189) announced its interim results for the six months ending June 30, 2026. The group achieved a revenue of 296 million yuan, a year-on-year increase of 30.75%; profit attributable to owners of the company was 10.2083 million yuan, compared to a loss of 6.4264 million yuan in the same period last year; earnings per share were 0.048 yuan.
Related Articles
LI AUTO-W (02015) delivered 37,679 new cars in August.
ZTO EXPRESS-W (02057) spent $4.9953 million to repurchase 234,200 shares on August 31.
ZHONGYU ENERGY (03633) spent HKD 1.5513 million to buy back 600,000 shares on August 31.
LI AUTO-W (02015) delivered 37,679 new cars in August.
ZTO EXPRESS-W (02057) spent $4.9953 million to repurchase 234,200 shares on August 31.
ZHONGYU ENERGY (03633) spent HKD 1.5513 million to buy back 600,000 shares on August 31.
RECOMMEND
